Alkira Bio on LinkedIn: Alkira Bio is excited to announce that we have secured a seed investment… | 17 comments
Summary
Alkira Bio is excited to announce that we have secured a seed investment from Curie.Bio. The funding will support the expansion of our revolutionary LASEREDD\xae platform, built to discover therapeutic antibodies directed against complex membrane proteins. Curie.Bio is a new model for venture capital in biotech, focused on giving founders the support and access they need to build successful therapeutics companies. Seed investment and co-piloting from Curie.Bio will enable Alkira Bio to leverage the unique capabilities of the LASEREDD\xae platform to deliver breakthrough medicines to improve the lives of patients.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected